It was launched in China in 1970. Its antimicrobial spectrum is the same as that of lincomycin, but it has stronger antibacterial activity. Clinically, it is mainly used for osteomyelitis, infections caused by anaerobes, respiratory system infections, biliary tract infections, endocarditis, otitis media, skin and soft tissue infections, and septicemia, etc. The most common adverse reactions in application include: allergic reactions, local injection site irritation, and abnormal liver function. The most severe one is pseudomembranous colitis (PMC).

Potent Antibacterial Activity: Demonstrates significant efficacy against Gram-positive bacteria such as Staphylococcus aureus and Streptococcus pneumoniae, as well as anaerobes.    

Mechanism of Action: Kills bacteria by inhibiting bacterial protein synthesis (binding to the 50S ribosomal subunit).    

Strong Tissue Penetration: Achieves high concentrations in tissues such as bone, joints, and lungs, making it suitable for treating bone infections and deep-seated infections.    

Good Stability: The active pharmaceutical ingredient (API) should be stored in a light-protected, sealed container and kept away from moisture.    

Wide Clinical Application: Used for skin infections, respiratory tract infections, intra-abdominal infections, and other conditions.